NIDA conference report on cardiopulmonary complications of 'crack' cocaine use: Clinical manifestations and pathophysiology

Chest

Volumn 110, Issue 4, 1996, Pages 1072-1076

  Thadani, Pushpa V ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

abused drugs; biological mechanisms; cardiovascular; cocaine; complications; crack; pathophysiology; pulmonary

Indexed keywords

COCAINE;

ARTICLE; CARDIOPULMONARY INSUFFICIENCY; DRUG ABUSE; HUMAN; LUNG INJURY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029962624     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.1072     Document Type: Article

References (42)

1. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995; 333:1267-72
2. Johnston LD, O'Malley PM, Bachman JG. National survey results on drug use from the monitoring the future study, 1975-93 (vol 2). College students and young adults. Washington, DC: National Institute on Drug Abuse, NIH publication No. 944-3810, 1994
3. Haim DY, Lippmann ML, Goldberg SK, et al. The pulmonary complications of crack cocaine: a comprehensive review. Chest 1995; 107:233-40
4. Tashkin DP, Khalsa ME, Gorelick D, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis 1992; 145:92-100
5. Itkonen J, Schnoll S, Glassroth J. Pulmonary dysfunction in "freebase" cocaine users. Arch Intern Med 1984; 144:2195-97
6. Suhl J, Gorelick DA. Pulmonary function in male freebase cocaine smokers. Am Rev Respir Dis 1988; 137:A488
7. Tashkin DP, Kleerup E, Hoh C, et al. Effects of smoked substance abuse on pulmonary alveolar permeability. Am J Respir Crit Care Med 1995; 155(pt 2):A97
8. Susskind H, Weber DA, Volkow ND, et al. Increased lung permeability following long-term use of free-base cocaine (crack). Chest 1991; 100:903-09
9. Chen LC, Graefe JF, Shojaie J, et al. Pulmonary effects of the cocaine pyrolysis product, methylecgonidine, in guinea pigs. Life Sci 1995; 56:PL7-12
10. Ettinger NA, Albin HJ. A review of the respiratory effects of smoking cocaine. Am J Med 1989; 87:664-68
11. Rao AN, Polos PG, Walther FA. Crack abuse and asthma: a fatal combination. NY State J Med 1990; 90:511-12
12. Rubin RB, Neugarten J. Cocaine-associated asthma. Am J Med 1990; 88:438-39
13. O'Donnell AE, Selig J, Aravamuthan M, et al. Pulmonary complications associated with illicit drug use: an update. Chest 1995; 108:460-63
14. Roth MD, Dubinett SM, Lee P, et al. Altered cytokine profiles from the lungs of tobacco, marijuana and cocaine users. Am J Respir Critical Care 1995; 151(pt 2):A138
15. 1. Immunology 1991; 146:81-4
16. Baldwin CG, Buckley DM, Roth MD, et al. Alveolar macrophages derived from lungs of tobacco, marijuana and cocaine users are functionally compromised [abstract]. Presented at the annual meeting of the College of Problems on Drug Dependence, Scottsdale. Ariz, June 1995
17. Mao J, Huang M, Lee P, et al. Cocaine modulates peripheral blood lymphocyte lymphokine production. Am J Respir Crit Care Med 1995; 151:A780
18. Bailey ME, Fraire AE, Greenberg SD, et al. Pulmonary histopathology in cocaine abusers. Hum Pathol 1994; 25:203-07
19. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 1990; 88:325-31
20. Kloner RA, Hale S, Alker K, et al. The effects of acute and chronic cocaine use on the heart. Circulation 1992; 85:407-19
21. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine associated chest pain. Acad Emerg Med 1994; 1:330-39
22. Hollander JE, Hoffman RS, Gennis P, et al. Cocaine associated chest pain: one year follow-up. Acad Emerg Med 1995; 2:179-84
23. Hollander JE, Hoffman RS, Burstein J, et al. Cocaine associated myocardial infarction: mortality and complications. Arch Intern Med 1995; 155:1081-86
24. Hoffman RS, Henry GC, Howland MA, et al. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med 1992; 21:247-53
25. Hoffman RS, Henry GC, Wax PM, et al. Decreased plasma cholinesterase activity enhances cocaine toxicity in mice. J Pharmacol Exp Ther 1992; 263:698-702
26. Branch CA, Knuepfer MM. Causes of differential cardiovascular sensitivity to cocaine: II. Sympathetic, metabolic and cardiac effects. J Pharmacol Exp Ther 1994; 271:1103-13
27. Knuepfer MM, Hoang D, Mueller PJ, et al. Variable hemodynamic responsiveness to behavioral stress and cocaine is related to differential CNS responsivity. Soc Neurosci 1995; 21: 795A
28. Knuepfer MM, Branch CA, Gan Q, et al. Cocaine-induced myocardial ultrastructural alterations and cardiac output responses in rats. Exp Mol Pathol 1993; 59:155-68
29. Virinani R, Robinowitz M, Smialek Smyth DF. Cardiovascular effects of cocaine: an autopsy of 40 patients. Am Heart J 1988; 115:1068-76
30. Numez BD, Miao L, Wang Y, et al. Cocaine-induced microvascular spasm in Yucatan miniature swine: in vivo and in vitro evidence of spasm. Circ Res 1994; 74:281-90
31. 1A-serotonergic and muscarinic receptor antagonists. FASEB J 1992; 6:A1578
32. Shannon RP, Stambler BS, Komamura K, et al. Cholinergic modulation of the coronary vasoconstriction induced by cocaine in conscious dogs. Circulation 1993; 87:939-49
33. Kolodgie FD, Wilson PS, Cornhill JF, et al. Increased prevalence of aortic fatty atreaks in cholesterol fed rabbits administered intravenous cocaine: the role of vascular endothelium. Toxicol Pathol 1993; 21:425-35
34. Kolodgie FD, Virmani R, Cornhill JF, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated vasospasm and thrombosis. J Am Coll Cardiol 1991; 17:1553-60
35. Kolodgie FD, Virmani R, Cornhill JF, et al. Cocaine: an independent risk factor for aortic sudanophilia: a preliminary report. Atherosclerosis 1992; 97:53-62
36. Rinder HM, Ault KA, Jatlow PI, et al. Platelet α-granule release in cocaine users. Circulation 1994; 90:1162-67
37. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine induced coronary artery vasoconstriction. N Engl J Med 1989; 321:1557-62
38. Eisenberg MJ, Mendelson J, Evans GT Jr, et al. Left ventricular function immediately after intravenous cocaine: a quantitative two-dimensional echocardiographic study. J Am Coll Cardiol 1993; 22:1581-86
39. Gillis RA, Hernandez, YM, Erzouki HK, et al. Sympathetic nervous system mediated cardiovascular effects of cocaine are primarily due to a peripheral site of action of the drug. Drug Alcohol Depend 1995; 37:217-30
40. Chen BX, Myles J, Wilkerson RD. Role of the sympathoadrenal axis in the cardiovascular response to cocaine in conscious unrestrained rats. J Cardiovasc Pharmacol 1995; 25:817-22
41. Wang SY, Nunez BD, Morgan JP, et al. Cocaine and the porcine coronary microcirculation: effects of chronic cocaine exposure and hypercholesterolemia. J Cardiothorac Vasc Anesth 1995; 9:290-96
42. Miao L, Qui Z, Morgan JP. Cholinergic stimulation modulates the negative inotropic effect of cocaine on ferret ventricular myocardium. Am J Physiol 1996; 39:H6782-84